World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
94
Citations
35390
World Ranking
10417
National Ranking
414

Felix Zijlstra publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Felix Zijlstra sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 787 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Felix Zijlstra D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Felix Zijlstra sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 94 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Felix Zijlstra is affiliated with Erasmus University Rotterdam in the Netherlands and specializes in medicine with a primary focus on cardiology and cardiovascular medicine. Their research contributions span various subfields including surgery, radiology, nuclear medicine and imaging, pulmonary and respiratory medicine, and biomedical engineering.

The scientist's work predominantly covers topics related to coronary interventions and diagnostics, cardiac imaging and diagnostics, acute myocardial infarction research, cardiovascular function and risk factors, antiplatelet therapy and cardiovascular diseases, cardiac valve diseases and treatments, and atrial fibrillation management and outcomes.

Felix Zijlstra has published extensively in prominent journals with frequent contributions to the following venues:

  • Journal of the American College of Cardiology
  • Cardiovascular Revascularization Medicine
  • JACC: Cardiovascular Interventions
  • Catheterization and Cardiovascular Interventions
  • EuroIntervention

Notable recent papers include:

  • Validation of a three-dimensional quantitative coronary angiography-based software to calculate fractional flow reserve: the FAST study, 2020, EuroIntervention
  • Dynamic Myocardial Perfusion CT for the Detection of Hemodynamically Significant Coronary Artery Disease, 2021, JACC: Cardiovascular Imaging
  • Impact of Poststenting Fractional Flow Reserve on Long-Term Clinical Outcomes, 2021, Circulation Cardiovascular Interventions
  • Intravascular Ultrasound-Guided versus Coronary Angiography-Guided Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction: A Systematic Review and Meta-Analysis, 2022, International Journal of Cardiology
  • FFR-Guided PCI Optimization Directed by High-Definition IVUS Versus Standard of Care, 2022, JACC: Cardiovascular Interventions

Felix Zijlstra collaborates regularly with several co-authors, including:

  • Nicolas M. Van Mieghem
  • Roberto Diletti
  • Wijnand K. den Dekker
  • Joost Daemen
  • Jeroen Wilschut

Best Publications

  • A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction.

    F. Zijlstra;M. J. De Boer;J. C. A. Hoorntje;S. Reiffers

  • Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction : A quantitative review

    W D Weaver;R J Simes;A Betriu;C L Grines

  • Thrombus Aspiration during Primary Percutaneous Coronary Intervention

    Tone Svilaas;Pieter J. Vlaar;Iwan C. van der Horst;Gilles F. H. Diercks

  • Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study

    Pieter J. Vlaar;Tone Svilaas;Iwan C. van der Horst;Gilles F. H. Diercks

  • Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction

    Arnoud Wj van't Hof;Aylee Liem;Menko-Jan de Boer;Felix Zijlstra

  • Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty.

    Giuseppe De Luca;Harry Suryapranata;Felix Zijlstra;Arnoud W J van 't Hof

  • Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial.

    Daniel J F M Thuijs;A Pieter Kappetein;Patrick W Serruys;Friedrich-Wilhelm Mohr

  • Angiographic Assessment of Reperfusion in Acute Myocardial Infarction by Myocardial Blush Grade

    Jose P.S. Henriques;Felix Zijlstra;Arnoud W.J. van ‘t Hof;Menko-Jan de Boer

  • Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis.

    Pieter J. Vlaar;Karim D. Mahmoud;David R. Holmes;Gert van Valkenhoef

  • Clinical characteristics and outcome of patients with early ( 4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction.

    Felix Zijlstra;A. Patel;M. Jones;C. L. Grines

  • Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis of 11 trials

    Francesco Burzotta;Maria De Vita;Youlan L. Gu;Takaaki Isshiki

  • Reperfusion therapy in elderly patients with acute myocardial infarction: a randomized comparison of primary angioplasty and thrombolytic therapy.

    Menko-Jan de Boer;Jan-Paul Ottervanger;Arnoud W J van 't Hof;Jan C A Hoorntje

  • Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: The glucose-insulin-potassium study: a randomized trial☆

    Iwan C.C. van der Horst;Felix Zijlstra;Arnoud W.J. van 't Hof;Catharina Jacoba Maria Doggen

  • Left ventricular thrombus formation after acute myocardial infarction

    Ronak Delewi;Felix Zijlstra;Jan J Piek

  • Prognostic Assessment of Patients With Acute Myocardial Infarction Treated With Primary Angioplasty Implications for Early Discharge

    Giuseppe De Luca;Harry Suryapranata;Arnoud W J van 't Hof;Menko-Jan de Boer

  • Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials

    Giuseppe De Luca;Dariusz Dudek;Gennaro Sardella;Paolo Marino

  • Prognostic Value of Microvascular Obstruction and Infarct Size, as Measured by CMR in STEMI Patients

    Matthijs van Kranenburg;Michael Magro;Holger Thiele;Suzanne de Waha

  • Familial sudden death is an important risk factor for primary ventricular fibrillation: a case-control study in acute myocardial infarction patients.

    Lukas R.C. Dekker;Connie R. Bezzina;José P.S. Henriques;Michael W. Tanck

  • Comparison of Primary Coronary Angioplasty and Intravenous Thrombolytic Therapy for Acute Myocardial Infarction: A Quantitative Review

    W. Douglas Weaver;R. John Simes;Amadeo Betriu;Cindy L. Grines

  • Long-Term Benefit of Primary Angioplasty as Compared with Thrombolytic Therapy for Acute Myocardial Infarction

    Felix Zijlstra;Jan C.A. Hoorntje;Menko-Jan De Boer;Stoffer Reifers

Frequent Co-Authors

Robert-Jan van Geuns
Robert-Jan van Geuns Radboud University
Peter de Jaegere
Peter de Jaegere Erasmus University Rotterdam
Evelyn Regar
Evelyn Regar University of Zurich
Wiek H. van Gilst
Wiek H. van Gilst University Medical Center Groningen
Eric Boersma
Eric Boersma Erasmus University Rotterdam
Patrick W. Serruys
Patrick W. Serruys University of Galway
Freek W.A. Verheugt
Freek W.A. Verheugt University Medical Centre Mannheim
Matthijs Oudkerk
Matthijs Oudkerk University of Groningen
Jan J. Piek
Jan J. Piek University of Amsterdam
Cindy L. Grines
Cindy L. Grines Wayne State University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative healthcare career paths in the U.S. is easier than ever, thanks to a range of flexible online programs. For those who hold a non-nursing bachelor’s degree and wish to transition quickly into nursing, consider direct entry msn programs online. These accelerated programs can fast-track your route to becoming a registered nurse and are designed for career changers.

Worried about tough admissions? There are nursing programs with high acceptance rates that offer a more accessible pathway into the profession, making it easier to start your nursing education journey.

If you prefer administrative healthcare roles, numerous medical billing and coding online schools that accept financial aid can help you get qualified remotely while minimizing up-front costs.

Additionally, some practical nursing pathways are available without entrance exam stress—look into an lpn program without teas test requirements for a streamlined application process.

With these varied options, you can pursue a healthcare career that matches your education goals, schedule, and background.

Best Scientists Citing Felix Zijlstra

Trending Scientists

Recently Published Articles